OVARY NEOPLASM
Clinical trials for OVARY NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new OVARY NEOPLASM trials appear
Sign up with your email to follow new studies for OVARY NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cell therapy for solid tumors shows early promise but trial halted
Disease control TerminatedThis study tested a personalized treatment where a patient's own immune cells were modified in a lab to recognize and attack unique mutations in their cancer. It was designed for people with advanced solid tumors like lung, pancreatic, or ovarian cancer who had not responded to s…
Matched conditions: OVARY NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…
Matched conditions: OVARY NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 05:43 UTC